Sort   by:  
 Page size 
UnknownEvaluation of Antiproliferative, Antimicrobial, Antioxidant, Antidiabetic and Phytochemical Analysis of Anogeissus dhofarica A. J. Scott.
Not available
S-EPMC9952305 | biostudies-literature
UnknownA candidate loss-of-function variant in SGIP1 causes synaptic dysfunction and recessive parkinsonism.
Not available
S-EPMC11513836 | biostudies-literature
UnknownWNT4 deficiency impacts heart, diaphragm, and palate development: Insights from human genetics, machine learning, and mouse models.
Not available
S-EPMC12706744 | biostudies-literature
UnknownThe risk of secondary progressive multiple sclerosis is geographically determined but modifiable.
Not available
S-EPMC10629760 | biostudies-literature
UnknownBiallelic variants in Plexin B2 (PLXNB2) cause amelogenesis imperfecta, hearing loss and intellectual disability.
Not available
S-EPMC11228227 | biostudies-literature
UnknownMutations in INPP5E, encoding inositol polyphosphate-5-phosphatase E, link phosphatidyl inositol signaling to the ciliopathies.
Not available
S-EPMC2746682 | biostudies-literature
UnknownWhole-exome sequencing identifies mutated c12orf57 in recessive corpus callosum hypoplasia.
Not available
S-EPMC3591854 | biostudies-literature
UnknownProgression independent of relapse activity and relapse-associated worsening in seronegative NMOSD: an international cohort study.
Not available
S-EPMC11996963 | biostudies-literature
UnknownReal-world effectiveness of horizontal switching between disease-modifying therapies in multiple sclerosis: a retrospective analysis of the MSBase Registry.
Not available
S-EPMC12744030 | biostudies-literature
UnknownComparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry.
Not available
S-EPMC9925904 | biostudies-literature
Sort   by:  
 Page size